BRPI0919475A2 - composição farmacêutica para administração oral - Google Patents

composição farmacêutica para administração oral

Info

Publication number
BRPI0919475A2
BRPI0919475A2 BRPI0919475A BRPI0919475A BRPI0919475A2 BR PI0919475 A2 BRPI0919475 A2 BR PI0919475A2 BR PI0919475 A BRPI0919475 A BR PI0919475A BR PI0919475 A BRPI0919475 A BR PI0919475A BR PI0919475 A2 BRPI0919475 A2 BR PI0919475A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
oral administration
oral
administration
pharmaceutical
Prior art date
Application number
BRPI0919475A
Other languages
English (en)
Inventor
Kazuhiro Sako
Shinsuke Oba
Tadashi Hakomori
Takehiko Yasuji
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of BRPI0919475A2 publication Critical patent/BRPI0919475A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0919475A 2008-09-30 2009-09-28 composição farmacêutica para administração oral BRPI0919475A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10135608P 2008-09-30 2008-09-30
PCT/JP2009/066741 WO2010038689A1 (ja) 2008-09-30 2009-09-28 経口投与用医薬組成物

Publications (1)

Publication Number Publication Date
BRPI0919475A2 true BRPI0919475A2 (pt) 2015-12-01

Family

ID=42073453

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0919475A BRPI0919475A2 (pt) 2008-09-30 2009-09-28 composição farmacêutica para administração oral

Country Status (14)

Country Link
US (1) US20100144711A1 (pt)
EP (1) EP2343076A4 (pt)
JP (2) JP4582263B2 (pt)
KR (1) KR20110071104A (pt)
CN (1) CN102170885A (pt)
AU (1) AU2009300751A1 (pt)
BR (1) BRPI0919475A2 (pt)
CA (1) CA2738912A1 (pt)
IL (1) IL212034A0 (pt)
MX (1) MX2011003444A (pt)
RU (1) RU2011117273A (pt)
TW (1) TW201021832A (pt)
WO (1) WO2010038689A1 (pt)
ZA (1) ZA201102405B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6866113B2 (ja) * 2016-11-01 2021-04-28 日本化薬株式会社 カペシタビンを有効成分とする医薬製剤
WO2024031226A1 (zh) * 2022-08-08 2024-02-15 无锡和誉生物医药科技有限公司 Fgfr抑制剂的药物组合物、多晶型物及其在药学上的应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE183642T1 (de) * 1991-10-04 1999-09-15 Yoshitomi Pharmaceutical Tablette mit verzögerter freisetzung
US20020028248A1 (en) * 1996-03-14 2002-03-07 Takayuki Tsukada Rapid-release microdispersible ecadotril preparation
JPH11322584A (ja) * 1998-05-07 1999-11-24 Sawai Pharmaceutical Co Ltd ベザフィブラート徐放性製剤
AU776053B2 (en) * 2000-03-31 2004-08-26 Astellas Pharma Inc. Diazepan derivatives or salts thereof
DK1336605T3 (da) * 2000-11-22 2006-06-19 Astellas Pharma Inc Substituerede phenolderivater eller salte deraf som inhibitorer af koagulationsfaktor X
JP4848558B2 (ja) * 2001-05-08 2011-12-28 トーアエイヨー株式会社 塩酸メトホルミン含有速放性錠剤
JP4732622B2 (ja) * 2001-06-28 2011-07-27 興和株式会社 トコフェロール製剤
JP4753567B2 (ja) * 2004-11-19 2011-08-24 旭化成ケミカルズ株式会社 付着性の高い薬物を含有する錠剤の製造方法
US20080031942A1 (en) * 2004-12-03 2008-02-07 Takeda Pharmaceutical Company Limited Solid Preparation
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
PE20070077A1 (es) * 2005-06-10 2007-02-07 Takeda Pharmaceutical Comprimido con recubierta con azucar
WO2007043538A1 (ja) * 2005-10-05 2007-04-19 Kyoto Pharmaceutical Industries, Ltd. 経口用組成物
JP2007186450A (ja) * 2006-01-13 2007-07-26 Nichi-Iko Pharmaceutical Co Ltd 塩酸パロキセチン含有製剤およびその製造方法
JP5295506B2 (ja) * 2006-02-21 2013-09-18 第一三共株式会社 レボフロキサシン含有錠剤
JP2007308456A (ja) * 2006-05-22 2007-11-29 Nichi-Iko Pharmaceutical Co Ltd 保存安定性に優れた塩酸イミダプリル含有製剤
WO2008066102A1 (fr) * 2006-11-30 2008-06-05 Takeda Pharmaceutical Company Limited Préparation à libération prolongée
JP2008222646A (ja) * 2007-03-13 2008-09-25 Takeda Chem Ind Ltd 固形製剤

Also Published As

Publication number Publication date
EP2343076A4 (en) 2012-01-18
CN102170885A (zh) 2011-08-31
US20100144711A1 (en) 2010-06-10
MX2011003444A (es) 2011-05-02
AU2009300751A1 (en) 2010-04-08
CA2738912A1 (en) 2010-04-08
WO2010038689A1 (ja) 2010-04-08
EP2343076A1 (en) 2011-07-13
JP2010235630A (ja) 2010-10-21
RU2011117273A (ru) 2012-11-10
TW201021832A (en) 2010-06-16
ZA201102405B (en) 2012-06-27
JPWO2010038689A1 (ja) 2012-03-01
KR20110071104A (ko) 2011-06-28
JP4582263B2 (ja) 2010-11-17
IL212034A0 (en) 2011-06-30

Similar Documents

Publication Publication Date Title
LTPA2018005I1 (lt) Farmacinė kompozicija
DK2328601T3 (da) Linaclotid-holdige formuleringer til oral indgivelse
BRPI0721651A2 (pt) Composição farmacêutica
HK1164059A1 (en) Compositions for drug administration
BRPI0919466A2 (pt) composição farmacêutica para liberação modificada
BRPI1007484A2 (pt) composição farmacêutica para administração oral
BRPI0820381A2 (pt) Formulações farmacêuticas
DK3492069T3 (da) Farmaceutiske sammensætninger omfattende jern-oxy-hydroxid
BRPI0818680A2 (pt) composição farmacêutica, preparação farmacêutica, e método para preparar um forma de dosagem oral farmacêutica
BRPI1008598A2 (pt) composição farmacêutica para inalação
DK2120884T3 (da) Farmaceutisk sammensætning
DK2285413T3 (da) Farmaceutisk sammensætning
DK2391349T3 (da) Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater
BRPI0921313A2 (pt) composição farmaucêutica
DK2542224T3 (da) Oral farmaceutisk sammensætning indeholdende dabigatranetexilat
BRPI0820198A2 (pt) composições farmacêuticas
BRPI0918539A2 (pt) preparação farmacêutica sólida para administração oral
BRPI0912171A2 (pt) composição farmacêutica
BR112013014940A2 (pt) composições farmacêuticas de inibidores de fator xa seletivos para administração oral
BRPI0912656A2 (pt) formulação farmacêutica sólida
BRPI0919194A2 (pt) preparação sólida para administração oral
BRPI0921301A2 (pt) composição farmacêutica
BRPI0919475A2 (pt) composição farmacêutica para administração oral
BRPI0906045A2 (pt) "composição farmacêutica para administração nasal"
BRPI0923379A2 (pt) Formulação para administração por via transmucosa oral de setronas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.